TRV-120027 TFA is an angiotensin II-mediated vasoconstriction inhibitor and increases cardiomyocyte contractility. TRV-120027 TFA is a beta-arrestin-1-biased AT1R agonist engaging ß-arrestins while blocking G-protein signaling[1]. TRV-120027 TFA induces acu
Molecular Weight:
1040.1
Formula:
C45H68F3N13O12
Target:
TRP/TRPV Channel|||Arrestin|||RAAS
* VAT and and shipping costs not included. Errors and price changes excepted